Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

AnGes and Morishita Jintan enter agreement regarding rights to CIN treatment vaccine

June 16, 2016

Worse progression-free survival seen in pelareorep treatment group in colorectal cancer trial

June 16, 2016

New ADC IMGN-632 shows promising preclinical results in AML

June 15, 2016

Clinical trial data delineate activity of pembrolizumab in advanced sarcoma and thyroid cancer

June 14, 2016

FDA awards orphan drug designation to Galena Biopharma's cancer immunotherapy peptide programs

June 13, 2016

Cantargia finalizes tests for CAN-04 before applying for clinical trials

June 13, 2016

Mologen shifts from research to product- and market-oriented company

June 10, 2016

Darvulumab monotherapy shows early evidence of clinical benefit in NSCLC patients

June 10, 2016

Update of clinical trials for cancer vaccine NY-ESO-1(c259) SPEAR T cells given at ASCO

June 9, 2016

First clinical data reported for anti-CD47 monoclonal antibody Hu5F9-G4

June 9, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...